Core Scientific, Inc.
CORZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4 | $1 | $1 | $1 |
| - Cash | $1 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $0 | $1 |
| Enterprise Value | $4 | $2 | $1 | $1 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 1.6% | -21.5% | 17.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 23.7% | 24.6% | 1.3% | 43.9% |
| EBITDA | -$1 | -$0 | -$2 | $0 |
| % Margin | -226.6% | -12.6% | -287.4% | 25.9% |
| Net Income | -$1 | -$0 | -$2 | $0 |
| % Margin | -257.5% | -49.1% | -335.2% | 8.7% |
| EPS Diluted | -5.14 | -0.65 | -6.3 | 0.2 |
| % Growth | -690.8% | 89.7% | -3,250% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |